Sector › Medicine
Press Releases
Etrasimod Receives Strong Recommendation in the ACG Clinical Guideline Update: Ulcerative Colitis in Adults for Induction and Maintenance Phase of Moderately to Severely Active UC
Everest Medicines Limited
Aug 15, 2025 20:15 HKT/SGT
艾曲莫德入選《2025 ACG臨床指南：成人潰瘍性結腸炎》，獲強烈推薦用於中重度潰瘍性結腸炎的誘導緩解及維持緩解治療
Everest Medicines Limited
Aug 15, 2025 20:07 HKT/SGT
艾曲莫德入选《2025 ACG临床指南：成人溃疡性结肠炎》，获强烈推荐用于中重度溃疡性结肠炎的诱导缓解及维持缓解治疗
Everest Medicines Limited
Aug 15, 2025 19:56 HKT/SGT
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million Respectively
OrbusNeich Medical Group Holdings Limited
Aug 15, 2025 19:11 HKT/SGT
業聚醫療2025年中期業績收入及純利雙雙增長 分別達8,360萬美元及1,980萬美元
OrbusNeich Medical Group Holdings Limited
Aug 15, 2025 18:53 HKT/SGT
业聚医疗2025年中期业绩收入及纯利双双增长 分别达8,360万美元及1,980万美元
OrbusNeich Medical Group Holdings Limited
Aug 15, 2025 18:10 HKT/SGT
Everest Medicines' New Drug Application for Etrasimod Accepted in Taiwan, Marking Another Milestone in Asia Market Access
Everest Medicines Limited
Aug 14, 2025 18:00 HKT/SGT
NMPA已受理亿胜生物关于EB12-20145P（HLX04-O）用于治疗湿性年龄相关性黄斑变性的生物制品许可申请
Essex Bio-Technology Limited
Aug 13, 2025 21:25 HKT/SGT
NMPA已受理億勝生物關於EB12-20145P（HLX04-O）用於治療濕性年齡相關性黃斑變性的生物製品許可申請
Essex Bio-Technology Limited
Aug 13, 2025 20:24 HKT/SGT
AsiaMedic Reports 26% Revenue Growth to S$16.6 million in 1H2025, Led by Strong Diagnostic Imaging Performance
AsiaMedic Limited
Aug 13, 2025 14:00 HKT/SGT
Kangji Medical Receives Privatisation Proposal from a Consortium Led by Kangji Medical's Chairman, Zhong Ming, TPG and QIA to Advance Long-Term Strategic Vision
Kangji Medical Holdings Limited
Aug 13, 2025 11:27 HKT/SGT
康基醫療收到由董事長鍾鳴、TPG及卡塔爾投資局(QIA)牽頭財團提出之私有化要約 助力公司實現長遠願景
Kangji Medical Holdings Limited
Aug 13, 2025 09:27 HKT/SGT
康基医疗收到由董事长钟鸣、TPG及卡塔尔投资局(QIA)牵头财团提出的私有化要约 助力公司实现长远愿景
Kangji Medical Holdings Limited
Aug 13, 2025 09:27 HKT/SGT
